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Abstract  
Objectives: Health care budgets within many countries are finite and 
decisions must be made about which interventions to provide and, by 
implication, which will not be provided. The aim of this study was to 
investigate what features of health care interventions, including the type of 
health gain, are important to members of the UK general public in making 
priority setting decisions and to understand more about the reasons why.   
Methods: Q methodology was used in a sample of 52 members of the public 
in North East England. Respondents rank ordered 36 health care 
interventions from those they would give highest priority to through to those 
they would give lowest priority to.  A form of factor analysis was used to reveal 
a small number of shared viewpoints.   
Results: From the factor analysis five factors emerged: ‘life saving to 
maximise the size of the health gain’, ‘everyone deserves a chance at life’, 
‘(potential for) own benefit’, ‘maximum benefit for (perceived) lowest cost’ and 
‘quality of life and social responsibility’.   
Conclusions: This study indicates that there are different views about which 
interventions should be given priority.  The factors revealed that respondents 
did consider the type of health gain received from an intervention but also 
highlighted other issues such as the size of the health gain, who received the 




In the UK quality adjusted life years (QALYs) have become the established 
measure of health outcome used in health care policy decision making.  The 
National Institute for Health and Clinical Excellence (NICE) has specified in its 
reference case that QALYs should be included as a measure of health 
outcome for submissions of technology appraisals for new interventions1. One 
of the main assumptions of the QALY is that people value the trade-offs 
between quality of life and life expectancy the same.  That is, they value a 
gain of one QALY which comes from an extra 1 year in full health the same as 
a one QALY gain arising from 10 years during which quality of life is improved 
by only 0.1 in each year (where 0 is death and 1 is full health).  This position 
is adopted by health technology assessment agencies, like NICE, who 
assume that QALYs are of equal value.  However, outside of these agencies 
there has been a tradition of questioning this, especially since the Oregon 
experiment2.   
 
Studies which have attempted to estimate the monetary value of a QALY from 
members of the public indicate that the type of QALY gain is important, with 
typically higher values for scenarios which include a reduction in the risk of 
death and lower values for studies in which the scenario is based on an 
improvement in quality of life only 3, 4. Although these studies have shown that 
the type of QALY gain is important to people there is little evidence as to why 
this is the case.  In this study Q methods were used to investigate what 
features of health care interventions, including the type of health gain, are 
important to members of the public and to understand more about the reasons 
why.  As the type of QALY is unlikely to be the only feature of health care 
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interventions people consider when setting priorities for health care funding, 
this study will also contribute a wider understanding of the views that 
members of the public hold.    
 
The next section of this paper describes the design of the Q study and the 
methods of data collection.  The factors which emerged from the study are 
then described in detail.  The paper concludes with some potential policy 
implications of the research.    
 
Methods 
The aim of this Q study was to explore the factors underlying the prioritisation 
of different health care interventions by members of the public and whether 
the components of the QALY were important in this. Q methodology is used to 
study “subjectivity” which can be described as an individual’s views, opinions 
or beliefs on any given topic5.  The stages of a Q study have been described 
in detail elsewhere 6, 7, therefore, only a brief overview is provided here.  The 
starting point of any Q study is to develop the concourse which represents all 
of the possible views on the topic in question8.  A set of statements (Q set) is 
derived from the concourse and provides the focus for data collection and 
analysis.  Each individual respondent is asked to provide their point of view on 
the statements by rank ordering them (usually according to agreement).  
Following the Q sorting exercise, a form of “by-person” factor analysis is 
conducted.  This analysis groups together similar Q sorts to reveal a small 
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number of underlying perspectives which are referred to as factors.  A 
‘composite’ Q sort can then be calculated to represent each factor. Through 
interpretation of the factors, rich descriptions of different points of view are 
generated.  Q methodology was chosen as a study of priorities naturally leads 
to methods which involve rank ordering either explicitly, or by inferring an 
order at the aggregate level based on respondents’ choices.   
 
Developing the Statements (The Q set) 
Generally in Q studies the concourse consists of statements of opinion on a 
particular topic which can be collected from sources such as interview 
transcripts, academic or popular literature7.  In this study the concourse 
consists of health care interventions currently provided by the NHS. To reduce 
this large concourse down to a smaller Q set a matrix was devised (Table 1).    
It was structured to make the Q set representative of the types and size of 
QALY gain people could get from health care interventions.  Four categories 
of health care intervention are represented in the Q set; quality of life 
enhancing interventions, life extending interventions, interventions which 
improve both quality of life and life expectancy and life saving interventions.  
Life saving interventions are defined as treatments which if not provided 
would result in premature death of the patient (clearly in the long term no 
intervention is life saving).  Life extending interventions in this study are those 
which give small reductions in the risk of death each year, which over the long 
term would lead to a longer life expectancy.  The size of the health gain was 
also included in the statements and the magnitude of QALY gains was 
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available for just under half of the interventions.  The type of disease was not 
specifically included in the matrix but when choosing the interventions an 
attempt was made to cover a large number of disease areas, including some 
that were likely to be less familiar.  As the statements in this study were not of 
the traditional discursive form, they will be referred to as "items" throughout 
the rest of this paper.   
[Table 1 about here] 
Once the matrix structure had been established a number of sources were 
used to obtain information for the Q set.  As a starting point, a general 
practioner was consulted who provided suggestions of medical and surgical 
interventions which could be classified under each of the four categories.  To 
supplement this and to supply information on the size of the health gain for 
each of the interventions, a search of the clinical guidelines produced by NICE 
and the NHS Health Technology Assessment Programme was undertaken9, 
10.  The aim was to select interventions to achieve an equal number of items 
representing the four types of health gain.  However, information on the size 
of the QALY gain was limited for the life extending interventions and the 
interventions which improve quality of life and life expectancy.  A total of 36 
interventions were included in the Q set (a full list of all the items is provided 
in Table 3).  Each item was printed onto a card in a standard format including 
an item number which was used for data recording purposes (see Figure 1 for 
an example).  
[Figure 1 about here] 
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Each card was ‘labelled’ with the name of the health care intervention, the 
condition in question and a brief explanation in lay terms.  The impact of the 
intervention on quality of life and life expectancy was detailed on each card 
together with the size of the health gain in terms of the number of QALYs 
generated for the average patient over their remaining lifetime.  
 
Sample (the P set) 
Sample selection in Q methodology has much in common with qualitative 
sampling techniques.  Respondents are sampled purposively in relatively 
small numbers sampling people who are likely to hold different views.  A large 
sample size is not required and analysis reaches saturation when no new 
views are expressed with typically 40-60 respondents being sufficient6.  A 
local social research company was contracted to recruit a sample of members 
of the public in North East England which was roughly balanced across age 
groups, employment status and gender (sample demographics are presented 
in Table 2). All respondents received £20 at the end of the session.   
 
 Conducting the Q sort  
The Q sorts were conducted through a series of 10 groups consisting of 
between 2 and 8 people per group.  At the beginning of each group, 
participants were told that the NHS operates with a limited budget therefore 
choices have to be made about which treatments to provide.  As each item 
also provided information on the size of the QALY gain from treatment, an 
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introduction to the concept of QALYs and how they are calculated was 
presented.  The study was set up as a societal problem with participants 
asked to consider the normative question of what interventions should be 
given priority while considering that the NHS operates with a fixed budget.  
Respondents were free to consider how prioritising the interventions might 
affect them personally, their immediate families and society more widely.  No 
attempt was made to restrict their perspective to either an individual or a 
citizen perspective since public values are likely to incorporate all of these 
(this issue will be returned to in the discussion).  To begin the Q sort each 
participant was given the pack of 36 cards (see column 2 Table 3). They were 
asked to read through each of the cards and sort them into three initial 
categories: those interventions they would give highest priority, those they 
would give lowest priority and those about which they were less sure.  
 
Once the initial sort was completed the participants were asked to rank order 
the items using the Q sorting grid (Figure 2).  The grid ranges from +4 
(highest priority) through to -4 (lowest priority).  It takes the form of a quasi-
normal distribution with fewer items placed in the tails of the distribution.  
Participants were then directed to record their final sorts on a response sheet 
which was printed with a small reproduction of the sorting grid and 
participants transcribed the item numbers according to their Q sort.  They also 
provided some written comments giving reasons why they had placed the 
cards in the +4 and -4 positions and any other general comments.   
[Figure 2 about here] 
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Participants took around 45 minutes to complete their sort.  Once all 
participants had completed the exercise a short group discussion was 
facilitated by the researcher to gain a better understanding of the views 
expressed by the participants in their sort. Participants were first asked to give 
general comments on the exercise before moving on to more specific 
questions about the placing of items, especially those at the extremes of the 
distribution.  Whilst participants commented on each other’s views, no 
changes to the Q sorts were made as a result of the discussion.  The 
discussion was digitally audio recorded this was used to aid the interpretation 
of the factors.  
 
Analysis  
In Q methodology a form of factor analysis is used to identify a small number 
of ‘shared viewpoints’.  The degree to which an individual agrees with the 
factor is given by their factor loading which is essentially a correlation 
coefficient, takes a value between -1 and +1, and represents the degree to 
which each Q sort is (dis) similar to each factor 11.  Factors are represented by 
a factor array, which is a composite Q sort 7 based on the average of the 
scores (i.e. +4 to -4) given to an item by all of the defining Q sorts.  These are 
Q sorts which are both significant for the factor (in this study this is a factor 
loading over 0.41 - an explanation of how this is calculated is shown under 
Table 4) but not significant on any other factor.   These scores are then 
weighted to reflect that some Q sorts are more highly associated with a factor 
than others 11.  A factor array can be laid out for each factor using the original 
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sorting grid by placing each item in the spaces on the grid as an aid to 
interpretation8. 
 
Analysis was conducted using PQMethod 2.11 12, a dedicated software 
package.  Principal components analysis was followed by varimax rotation to 
derive the factors (for further explanation of factor analysis in Q methodology 
see Brown 6).  
  
Results 
Fifty two people took part in the exercise.  The characteristics of those who 
took part are presented in Table 2.   
[Table 2 about here] 
A range of factor solutions based on 2 to 5 factors were explored.  A 5 factor 
solution was chosen even though the fifth factor has only 4 significant Q sorts 
(and 2 defining sorts) because it provided a solution that was most consistent 
with the views expressed by those participants based on their comments 
during group discussions and the brief written summaries they provided. 
Three and four factor solutions did not allow this account to emerge. The 
factor arrays for all five factors are presented in Table 3.  Table 4 presents the 
factor loading for each participant on each of the five factors.     
[Table 3 about here] 
[Table 4 about here] 
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Factor 1 – “Life saving to maximise the size of the health gain” 
Interventions which were described as life saving were given highest priority 
in Factor 1 on the basis that they give the largest health gain in terms of the 
number of life years gained.  This focus on the size of the health gain that 
would be received from a treatment is reflected in the comments provided by 
the respondents during the post-sort discussion and in their written 
comments:  
“Renal replacement therapy can help a sick patient to have more life 
years” (ID4, female, age 29) 
“[referring to neonatal intensive care] babies have potentially their full 
life ahead of them so saving 79 years” (ID42, female, 43) 
 
The rule-of-rescue was another feature of the life saving interventions which 
was important to this factor.  Treatments that would be conducted as an 
emergency or needed to be done urgently were given higher priority (items 4, 
appendectomy, (+2) and 33, salpingectomy, (+3)).  Similarly interventions 
which were deemed to be non urgent or pose no immediate threat to patients 
were given lower priority by this factor.   
 
Culpability is also a key issue for this factor, with interventions which could be 
caused by the patient’s lifestyle given low priority (items 12, orlistat, (-4) and 
2, counselling for alcoholism, (-4)).  Lifestyle diseases are seen by 
respondents associated with this factor as being in the control of the patient: 
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“Because smoking and obesity are in the control of most individuals” 
(ID42, female, 43) 
“Everybody knows about the negative effects of drinking alcohol so 
they should know how much they have drunk and how to [stop] 
drinking” (ID4, female, 29) 
 
Related to this issue of control was the perception that these interventions (or 
alternatives to them) are available outside of the NHS and that patients should 
buy such treatments themselves.   
 
Factor 2 – “Everyone deserves a chance at life” 
Similarly Factor 2 is also concerned with life saving but with a focus on the 
age of patients.  Children are given priority for two reasons: firstly they would 
receive the greatest increase in life expectancy (maximising benefit) and 
secondly because they ‘deserve a chance at life’.   
 
“Neonatal intensive care and Ectopic pregnancy are highest priority 
simply because highest priority has to go to the youngest patients 
because everyone deserves a chance at life” (ID25, male, 22) 
“Priority goes to children – anything which has the greatest increase 
in life expectancy must be prioritised” (ID48, male, 21)  
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Like Factor 1, culpability is important with treatments for alcoholism and 
obesity in the -4 position and higher priority has been given to interventions 
for diseases where the patient had no control over the cause of the disease.  
Thus, inherited diseases such as cystic fibrosis ((F1) +1, (F2) +2, (F3) 0, (F4) 
-2, (F5) -1) and sickle cell anaemia (0, +1, 0, -2, -2,) have positive factor 
scores and are both distinguishing items for this factor.  
 
Children were regarded by many participants as blameless for their illness 
which contributed to the focus on interventions for the young being given 
highest priority;  
“The treatments are for children that are not to blame for their illness 
and have their whole life ahead of them” (ID28, female, 22) 
 
It is interesting to note the age distribution of the 18 participants who load onto 
this factor.  The median age is 22 years and eight of the respondents with 
significant loadings on Factor 2 are students. Although Q studies are not 
designed to be representative across populations and are based on small 
numbers, it is possible that there is some relationship between the low age of 
the group and the focus on young people in the factor array.  However without 
a subsequent study of a representative population sample it is not possible 
from the data available to make a more conclusive link.  
 
Factor 3 – “(potential for) own benefit” 
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Factor 3 is concerned with the personal experiences of respondents and the 
people around them.  The focus is on interventions from which they believe 
they would benefit personally.  The type of QALY gain appears not to be 
important.  Rather the type of disease plays a more important role in the 
decision.  Four of the interventions given highest priority were for heart 
disease and several respondents’ comments indicate that they feel they would 
benefit either now or in the future from the provision of heart disease 
interventions, 
“Having heart problems, I feel they take the most problems and are 
required for myself” [referring to item 15] (ID35, male, 57)  
“At 72 two areas [Alzheimer’s and arrhythmias] where I might need 
help the most” (ID33, male, 72) 
 
Although the general theme of the factor is on the personal benefit that would 
be received from treatment, one participant did indicate that treatments for 
heart disease should be provided as it was likely to affect a large number of 
people in society 
“Probably the biggest potential killer diseases affecting large numbers 
of people?” [referring to items 5 and 31] (ID31, male, 66)   
 
The focus on heart disease may also be linked to the age range of the 
participants who have high factor loadings on this factor.  The average age of 
the respondents is 59 years with a median age of 66 years which is notably 
higher than any of the other factors.  Higher priority has been given to 
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interventions for cancers, Alzheimer’s disease as well as heart disease all of 
which predominantly affect older people in society.    
 
Like Factors 1 and 2, lower priority was given to interventions which were 
seen to be self inflicted and participants thought that treatment could be 
sought outside the NHS.  An individual perspective was also adopted with 
regard to lower priority interventions as is shown in the comments, 
“Smoking and alcoholism at the bottom as I don’t drink or smoke.  I 
just bought a new car as I don’t drink” (ID8, male, 82) 
 
A somewhat unusual feature of Factor 3 is the positioning of item 21, which is 
an intervention for sudden infant death syndrome, in the -4 position.  This is a 
distinguishing item for this factor (0, +3, -4, +3, 0).  However, it is difficult to be 
clear on the reasons for the positioning of this item from the qualitative 
comments provided.  Item 33, salpingectomy for Ectopic pregnancy (+3, +2, -
2, 0, +2), is also distinguishing for factor 3.  There may be a link between the 
positioning of this card, the individualistic approach of these respondents and 
the demographics of the participants who load onto this factor but it is not 
possible to be sure.  
 
Factor 4 – “maximum benefit for (perceived) lowest cost” 
Factor 4 was concerned with use of NHS resources to benefit the maximum 
number of people. Treatments which respondents considered best value for 
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money are given priority in this account despite the fact that no information is 
given on the cost of each item.   
 
The items which are ranked highest for this factor relate to diseases which 
affect large numbers of the population but where the intervention is likely to be 
lower cost 
“Based on straightforward low cost for maximum benefit.  Acute MI, 
appendicitis are straightforward and affect many” (ID40, male, 38) 
 
However, no discussion was given to the overall health care budget and how, 
if many people are affected, the overall budget may have to be increased.  
The focus appears to be on using low cost per person technologies even if the 
overall cost is higher than for a high cost intervention used by a smaller 
percentage of the population.  This is further evident in the positioning of item 
13 (air ambulance) in the factor array in the -4 position which is a 
distinguishing item for Factor 4 (0, +3, +1, -4, +2).  Many of the participant 
comments expressed the high cost element of the air ambulance and the 
number of people they would help, 
“Lowest priority is to air ambulance as the number of people 
benefiting would be small and very expensive” (ID29, male, 67) 
 
This concern about the costs of treatments was also used as an argument for 
preventive treatments.  Items 1 (flu vaccine (-1, 0, -1, +2, -2)) and 10 (smoking 
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cessation (-3,-3, -2, +4,+3)), distinguishing items for this factor, show how 
highly these preventative interventions are regarded in comparison to where 
they were placed by the other factors. 
 
There is no discussion in this account of self infliction or blame.  So called 
‘lifestyle diseases’ are given high priority which differentiates this from 
previous factors,    
“Don’t think alcoholism is self inflicted, [it] probably doesn’t cost very 
much [to give the advice] and can probably make a big difference”  
(ID1, male, 37) 
 
The placing of item 2 (counselling for alcoholism) reflects this view receiving a 
positive score compared with factors 1, 2 and 3 (-4, -4, -4, +3, +4).    
 
Factor 5 – “quality of life and social responsibility” 
The size of the health gain is less important in factor 5 and quality of life 
carries more weight than in any of the other factors.  Personal experiences of 
the participants with high loadings on this factor have also influenced their Q 
sorts.   
 
There is a mixture of quality of life enhancing and QALY gaining interventions 
in the highest priority section of the Q grid.  Of the life saving interventions, 
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only the air ambulance was ranked in the top two columns by this factor.  The 
importance of quality of life was emphasised by one participant commenting 
on item 18, 
“Quality of life is very important.  Alzheimer’s is likely to become a 
large problem as more of us live longer.  Long life expectancy with 
Alzheimer’s is grim for everyone” (ID34, female, 38) 
 
However, a number of quality of life enhancing interventions have been given 
lower priority.   The participants’ comments suggest that they made some kind 
of judgement about the societal value of treatments for varicose veins and 
Viagra which were regarded as cosmetic or unimportant.   
 
A distinguishing item for this factor is smoking cessation for COPD (-3, -3, -2, 
+4, +3) which is given a positive factor score.  Like Factor 4, both smoking 
cessation and counselling for alcoholism are given high priority by Factor 5.  
The qualitative comments for this factor indicate that culpability is not a 
consideration, instead there was a perceptible view that society has a 
responsibility to help people with diseases which may be caused by lifestyle 
such as alcoholism and obesity, 
“interventions earlier on are more important to prevent obesity in the 
first place.  Society definitely does have a duty to address the 






The aim of this study was to investigate what features of health care 
interventions, including the type of health gain, are important to members of 
the public when making judgements about which health care interventions to 
prioritise and to understand more about the reasons why.  Five factors were 
identified: (F1) “Life saving to maximize the size of the health gain”; (F2) 
“Everyone deserves a chance at life”; (F3) “(Potential for) own benefit”; (F4) 
“Maximum benefit for (perceived) lowest cost”; (F5) “Quality of life and social 
responsibility”.    
 
These five factors indicate that respondents do take account of the type of 
health gain which arises from treatment but there are also other issues which 
are important to them.  For factors 1 and 2 the QALY gains associated with 
life saving interventions are valued more highly than those which are life 
extending or quality of life enhancing. However, the factors present two 
distinct explanations for prioritising life saving interventions both of which are 
familiar from the health economics literature.  The first relates to health 
maximisation and interventions which yield the greatest health benefits are 
prioritised.  The maximisation of health gain (measured here in terms of the 
number of QALYs gained) is generally viewed as one of the main objectives 
of the health care system 13.  The second account takes a ‘fair innings’ view 14 
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with priority given to life saving interventions for younger people who were 
seen not to have had a fair chance at life.  This preference for younger people 
has also been expressed in a number of other studies 15-17.  Although other 
studies have found that members of the public prioritised life saving 
interventions the explanation as to why they are given priority has generally 
been based on a rule of rescue argument 18.  The results of this study indicate 
two alternative reasons for preferring life saving interventions which may be 
related to the type of interventions presented in the Q set.   
 
An issue which has become increasingly prominent in the UK is whether 
treatments which provide small increases in life expectancy for patients with 
terminal illness should be provided.  These interventions are often portrayed 
as life saving interventions as they are for people whose death can be 
considered premature.  A policy debate on whether these interventions should 
be provided is ongoing and NICE has recently relaxed its guidance on cost 
effectiveness for these types of interventions 19.  While the results of this study 
do show that, to some people, life saving interventions are regarded as more 
important, caution must be used in making comparisons between the types of 
life saving interventions used in this study and those currently being 
considered by NICE.  The interventions presented in this study produce health 
gains which are much larger than those which are subject to consideration by 
NICE where benefits are often a gain in life expectancy of only a few months.  
As can be seen by the explanations given by respondents associated with 
Factors 1 and 2, the size of the health gain is important in making this 
distinction between life saving interventions and all other interventions.  
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Further research is needed to examine the views of the public for 
interventions which result in small health gains.   
 
Personal responsibility was important for three of the factors with counselling 
for alcoholism and smoking cessation for COPD given low priority. In contrast 
the other two factors were more concerned with social responsibility, leading 
to the same interventions being given high priority.  This conflict between the 
factors on the issue of culpability is perhaps not surprising.  There is mixed 
evidence within the literature regarding the extent to which a person’s lifestyle 
should influence whether they receive treatment. In a small number of studies 
which have examined preferences for treatment for people with liver disease 
results have found that there is a preference for giving lower priority to 
patients whose illness was as a result of their lifestyle 20, 21. However, in the 
case of liver disease the issue of culpability maybe confounded by the fact 
that treatment is generally a transplant where there is real scarcity in 
availability.  Therefore this result may not be seen when looking at other 
disease areas in which there are more treatment options.  More mixed results 
have been reported in studies which look at the general principles relating to 
culpability 18, 22.  The results of a Q methodology study conducted as part of 
the Social Value of a QALY (SVQ) project 22 found that respondents did not 
think that patient lifestyle should be taken into account when asked to 
consider the principles the health service should use when deciding on how 
resources should be allocated.   The differences in the results between the 
study reported here and the SVQ study may be related to the type of 
statements in the Q sets. The SVQ study presented statements of general 
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principles for health care resource allocation rather than specific treatments 
as used in this study.  This suggests that there may be different ‘level’s at 
which people will agree with a proposition 23,  such as agreeing at a general 
policy level that there should be equal access to health care but making 
distinctions about the specific types of treatment that should be provided 
which no longer results in equal access to health care.  Investigating public 
preferences across the different levels of decision making and the impact this 
has on policy is an important area for future research.  
 
For this study it was decided that the name of the disease and the 
interventions should be included in the item description rather than presenting 
generic, unlabelled interventions.  This was to enable respondents to identify 
with the interventions and to try and prevent respondents making different 
assumptions about what the intervention might be.  This has potentially 
resulted in a labelling effect with diseases that were more familiar to the 
respondents being seen more in the tails of the distribution and therefore also 
more prominent in the group discussion while those interventions which were 
less familiar to respondents being seen more in the middle of the distribution.  
It was important to cover a wide range of disease areas to try and make 
respondents aware that decisions have to be made about all interventions in 
reality.  At the end of the Q sort many respondents did comment that they 
found the exercise challenging which may also have resulted in those 
interventions with which they were most familiar being placed in the tails of 
the Q grid.       
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An interesting feature of the results of the study was the perspective taken by 
the respondents in completing their Q sort.  As part of the general introduction 
to the Q sort exercise the issue of priority setting within the NHS was posed 
as a societal problem thus veering respondents towards a citizen perspective, 
although people could take a more selfish perspective.  It was important not to 
constrain the perspective from which people conducted their sort as when 
thinking about their views on health policy respondents are citizens, 
individuals, family members and potential patients and it is appropriate that 
they can consider all of these things when Q sorting.   
 
A number of the issues which have been highlighted in this study have been 
debated by policy makers, such as the NICE end of life guidance 19, and 
decisions are made without rigorous evidence about the views of members of 
the public.  The results of this study provide useful information to those who 
wish to use the views of members of the public in the decision making 
process such as the reasoning around the prioritisation around lifesaving 
interventions and the discussions both for against considering personal 
responsibility in making decisions.  If confirmed in a large, nationally 
representative sample, it could also be useful for agencies that seek to 
represent the views of members of the public, such as NICE’s Citizen’s 
Council or as part of consultations, that they might represent people 
associated with different viewpoints, especially as there is some conflict 
between the factors.  Consensus items across factors can also prove useful 
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for policy makers.  In this study there was only one consensus item, with all 
respondents giving low priority to the provision of Viagra with the general view 
being that this was something people could purchase outside of the NHS.   
 
This study has shown that when people are asked to think about prioritising 
health care, they consider more than just the magnitude of the health 
outcomes (in the form of the QALY) to make their decisions.  Future research 
will focus on the differences between stated principles and specific priorities, 
developing a greater understanding of the views on interventions which result 
in small health gains and development of Q techniques to examine the extent 
to which the views which arise in a Q study are found in larger, nationally 
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Table 1.  Q set Matrix 
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 Table 3.  Q items and Factor Arrays 
# Item F1 F2 F3 F4 F5 
1 Influenza vaccine (flu), flu vaccine 
for types A and B to prevent the 
complications associated with flu, 
does not improve quality of life, 
increases life expectancy, 6.4 
QALYs gained 
-1 0 -1 2 -2 
2 Counselling (alcoholism), 
counselling session for heavy 
drinkers to provide motivation and 
help to reduce alcohol intake, 
improves quality of life, increases life 
expectancy, 0.4 QALYs gained 
-4 -4 -4 3 4 
3 Neonatal intensive care (premature 
babies), incubation and treatment in 
intensive care unit for premature 
babies, intervention is life saving, no 
information available on the number 
of life years gained,   
3 4 1 0 0 
4 Appendectomy (appendicitis), 
surgical removal; of the appendix to 
treat appendicitis, intervention is life 
saving, 64 life years gained in full 
health 
2 2 0 3 0 
5 Statins (chronic heart disease), 
reduce the level of blood cholesterol, 
does not improve quality of life, 
increases life expectancy, no QALY 
information available 
0 -1 3 1 0 
6 Interferon Alpha (hepatitis C), 
treatment for hepatitis C a disease 
which affects the functioning of the 
liver, does not improve quality of life, 
increases life expectancy, no QALY 
information available 
-1 0 -2 -2 1 
7 Capecitabine (breast cancer), 
chemotherapy for breast cancer, 
does not improve quality of life, 
increases life expectancy, 0.8 
QALYs gained 
1 4 1 2 1 
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8 Drug treatment for early 
thrombolysis (acute myocardial 
infarction), early drug treatment to 
breakdown blood clots following a 
heart attack, intervention is life 
saving, 14 life years gained in full 
health 
4 2 3 4 2 
9 Surgery (varicose veins), surgical 
removal of varicose veins in the leg, 
improves quality of life, does not 
increase life expectancy, no QALY 
information available 
-2 -2 -2 -1 -3 
10 Smoking cessation (chronic 
obstructive pulmonary disease), 
quitting smoking to prevent the 
onset and progression of COPD a 
chronic lung disease, improves 
quality of life, increase life 
expectancy, no QALY information 
available 
-3 -3 -2 4 3 
11 rhDNase therapy (cystic fibrosis), 
treatment to improve lung function 
and reduce incidence and severity of 
lung infections, improves quality of 
life, increases life expectancy, 2 
QALYs gained 
1 2 0 -2 -1 
12 Orlistat (obesity), drug treatment 
which prevents the absorption of 
some fats in the intestine, improves 
quality of life, increases life 
expectancy, 0.02 QALYs gained 
-4 -4 -1 -4 -3 
13 Air ambulance service, helicopter 
ambulance service to provide quick 
assistance in emergency rescue, 
intervention is life saving, no 
information available on the number 
of life years gained 
0 3 1 -4 2 
14 Angiotensin converting enzyme 
(ACE) inhibitors (hypertension in 
Type 2 diabetes), drug treatment to 
reduce high blood pressure in 
people with type 2 diabetes, 
improves quality of life, increases life 
expectancy, 0.39 QALYs gained 
1 0 0 -2 -2 
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15 Implantable cardio defibrillators 
(arrhythmias), keeps the heart rate 
regular and in normal rhythm to 
reduce the risk of sudden cardiac 
death, does not improve quality of 
life, increases life expectancy, 0.75 
QALYs gained 
-1 0 3 1 1 
16 Coronary artery bypass graft 
(coronary artery disease), surgery to 
move a blood vessel from elsewhere 
in the body and use it to bypass a 
blocked coronary artery, improves 
quality of life, increases life 
expectancy, 0.3 QALYs gained 
2 1 4 -1 3 
17 Bone marrow transplant (sickle cell 
disease), bone marrow transplant to 
cure sickle cell disease, which 
affects the body’s red blood cells, 
does not improve quality of life, 
increase life expectancy, no QALY 
information available 
0 1 0 -2 -2 
18 Cholinesterase inhibitors 
(Alzheimer’s disease), drug 
treatment to slow functional decline 
in people with Alzheimer’s disease, 
improves quality of life, does not 
increase life expectancy, no QALY 
information available 
-3 1 4 -1 4 
19 Inhalers (asthma), quick relievers to 
ease the symptoms of asthma, 
improves quality of life, does not 
increase life expectancy, 7 QALYs 
gained 
2 0 0 2 -1 
20 Chemotherapy and surgery 
(colorectal cancer), surgical removal 
of tumour followed by chemotherapy 
for treatment of early colorectal 
cancer, intervention is life saving, 4 
life years gained in full health 
3 2 2 1 1 
21 Advice on sleeping positions 
(sudden infant death syndrome), 
advice for new parents from health 
care practioner on sleeping positions 
for children to reduce the risk of 
SIDS, intervention is life saving, 79 
0 3 -4 3 0 
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life years saved in full health 
22 Cataract extraction, surgical removal 
of a cataract in one eye, improves 
quality of life, does not increase life 
expectancy, 1.7 QALYs gained 
-2 -2 2 2 -1 
23 Antiretroviral therapy (HIV), 
combination of highly active 
antiretroviral drugs to slow down the 
progression of HIV, does not 
improve quality of life, increases life 
expectancy, 2.4 QALYs gained 
-2 -1 -2 1 0 
24 Renal replacement therapy (end 
stage renal disease), dialysis or 
transplant for severe kidney failure, 
intervention is life saving, 23 life 
years gained in less than full health 
if receiving dialysis 
4 3 1 -1 -1 
25 Metal on metal hip resurfacing (hip 
disease), repair of diseased hip joint, 
improves quality of life, does not 
increase life expectancy, no QALY 
information available 
-1 -2 0 0 2 
26 Thiazide and β blockers 
(hypertension), drug treatment to 
reduce blood pressure, does not 
improve quality of life, increases life 
expectancy, 0.8 QALYS gained 
-2 -1 2 -2 2 
27 Cholecystectomy (gallstones), 
surgical removal of gallstones to 
prevent blockage of cystic duct and 
infection of the gall bladder, 
improves quality of life, increases life 
expectancy, no QALY information 
available 
2 -1 -1 -1 1 
28 Continuous positive airway pressure 
(sleep apnoea), use of machine and 
facial mask to regulate air pressure 
to the nose and mouth to prevent 
airway collapsing during sleeping, 
improves quality of life, increases life 
expectancy, no QALY information 
available 
-2 0 -3 0 -1 
 31 
29 Laparoscopic surgery (inguinal 
hernia), surgery to repair a hernia in 
the groin, improves quality of life, 
does not increase life expectancy, 3 
QALYs gained 
1 -2 1 0 -3 
30 Infliximab (Crohn’s disease), 
treatment to reduce inflammation in 
the intestines and reduce the 
symptoms of Crohn’s disease, 
improves quality of life, does not 
increase life expectancy, 0.05 
QALYs gained 
-1 -1 -1 -3 -4 
31 Aspirin (stroke), medical treatment to 
be taken within 2 days of a stroke 
occurring, improves quality of life, 
increases life expectancy, no QALY 
information available 
0 1 2 2 -2 
32 Insulin (type 1 diabetes), long lasting 
insulin for treatment of type 1 (insulin 
dependant) diabetes, does not 
improve quality of life, increases life 
expectancy, no QALY information 
available 
1 1 2 0 0 
33 Salpingectomy (Ectopic pregnancy), 
surgical treatment for Ectopic 
pregnancy, intervention is life 
saving, no information available on 
the number of life years gained 
3 2 -2 0 2 
34 Acetylcysteine (paracetamol 
overdose), drug treatment in hospital 
for attempted suicide by 
paracetamol overdose, intervention 
is life saving, 19 life years gained in 
full health  
2 -3 -3 1 -2 
35 Viagra (erectile dysfunction), 
treatment for impotence in men, 
improves quality of life, does not 
increase life expectancy, 0.11 
QALYs gained 
-3 -3 -3 -3 -4 
36 Glucosamine sulphate 
(osteoarthritis), pain relief 
medication, improves quality of life, 
does not increase life expectancy, 
no QALY information available 
0 -2 -2 -3 2 
 32 
Shading indicates consensus items 
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Table 4. Factor loadings with X indicating a defining sort 
Q sort Age Gender  F1 F2 F3 F4 F5 
1 37 Male 0.12 -0.06 -0.23 0.68X 0.40 
2 77 Female  0.30 0.34 0.51 -0.26 0.18 
3 40 Female 0.53 0.18 0.50 -0.02 0.23 
4 29 Female 0.54X 0.32 0.29 0.19 -0.05 
5 38 Male 0.17 0.57X 0.50 -0.06 0.19 
6 23 Male 0.17 0.21 0.11 -0.53X -0.18 
7 68 Female 0.20 0.54X 0.44 -0.01 0.01 
8 82 Male 0.38 -0.03 0.61X -0.0003 -0.21 
9 64 Male -0.06 0.47 0.45 0.45 -0.20 
10 77 Male -0.03 -0.15 0.65X -0.19 -0.13 
11 60 Female 0.35 0.64X 0.16 -0.12 0.17 
12 19 Female -0.06 0.32 0.54 0.18 0.45 
13 20 Female 0.23 0.78X 0.25 0.18 -0.05 
14 42 Male 0.61 0.36 -0.03 0.48 -0.18 
15 23 Female 0.30 0.60X 0.41 0.0027 0.1 
16 54 Male 0.03 0.45 0.22 0.48 -0.32 
17 19 Female 0.10 0.74X 0.20 0.01 0.21 
18 21 Female 0.30 0.69X -0.12 -0.17 0.13 
19 35 Male 0.38 0.33 0.44 -0.06 0.08 
20 21 Male 0.06 0.70X -0.02 0.16 -0.25 
21 23 Male 0.20 0.08 -0.21 0.68X -0.12 
22 20 Male 0.45 0.58X 0.04 0.09 0.28 
23 56 Male 0.74X 0.19 0.25 0.06 0.08 
24 20 Male 0.25 0.65X 0.33 -0.04 0.11 
25 22 Male 0.28 0.83X 0.11 0.01 0.15 
26 24 Male -0.19 0.36 -0.01 0.24 0.63X 
27 39 Female 0.37 0.60X 0.31 0.19 0.18 
28 22 Female 0.23 0.82X 0.17 -0.05 0.15 
29 67 Male 0.07 0.03 -0.02 0.75X -0.05 
30 72 Male 0.50 0.19 0.53 0.07 0.03 
31 66 Male 0.11 0.34 0.65X -0.15 -0.08 
32 75 Male 0.15 0.49 0.55 0.06 -0.28 
33 72 Male 0.14 0.36 0.67X -0.05 0.14 
34 38 Female 0.13 -0.08 0.36 0.10 0.70X 
35 57 Male 0.17 0.20 0.77X -0.20 0.16 
36 21 Male 0.34 -0.34 0.28 0.62X 0.15 
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37 22 Male 0.23 0.83X 0.09 0.02 -0.21 
38 40 Female 0.57 0.42 -0.15 0.46 0.03 
39 61 Male 0.15 0.72X 0.38 0.12 0.25 
40 38 Male -0.01 0.17 0.09 0.50X 0.08 
41 61 Male 0.56 0.48 0.28 0.01 0.0002 
42 43 Female 0.66X 0.54 0.19 0.07 0.10 
43 41 Female 0.42 0.34 0.35 0.28. 0.16 
44 67 Female 0.52X 0.36 0.18 -0.21 0.06 
45 35 Female 0.21 0.59X 0.21 0.41 0.14 
46 32 Male 0.52 0.59 -0.02 0.37 -0.05 
47 25 Male 0.32 0.47 0.23 0.22 -0.20 
48 21 Male 0.41 0.68X 0.19 0.18 -0.13 
49 30 Male 0.74X 0.32 -0.02 0.07 -0.13 
50 44 Female -0.01 -0.01 0.68X 0.29 0.27 
51 21 Male 0.31 0.50 -0.02 -0.22 0.51 




  12 23 13 9 5 
Eigen 
value 
  6.27 11.8 6.95 4.43 2.74 
*Significant loadings are shown in bold type. Significance at the 1% level is taken as a factor 
loading greater than (2.58 x 1/√n where n= the number of statements – so in this case 
significant loadings are those higher than 0.41. Defining sorts which are used to construct the 
factor array are identified by an X.  X is calculated using a PQMethod algorithm which flags a 




/2 and (2) a > 1.96.  This indicates that the factor loading must 
explain more than half of the common variance and that it is a significant loading at the 5% 
level.   
 
 35 
Figure 1.  Example Q item  
Cataract Extraction 
22 
Surgical removal of a cataract in 
one eye 
Improves quality of life 
Does not increase life 
expectancy 
1.7 QALYS gained  
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